
Fidelity USD Digital Liquidity Fund-Acc
FILQ-A
Fundamental comparison between Fidelity USD Digital Liquidity Fund-Acc and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Detailed Comparison
| Metric | Fidelity USD Digital Liquidity Fund-Acc | Injective |
|---|---|---|
| Price | $100.78 | $4.90 |
| Market Cap | $45.18M | $489.86M |
| 24h Volume | 0 | 61.8M |
| Rank | #— | #— |
| Circulating Supply | 448.3K | 100M |
| ATH | $100.78 | $52.62 |
Fidelity USD Digital Liquidity Fund-Acc vs Injective — Analysis
Fidelity USD Digital Liquidity Fund-Acc and Injective are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 43.6, Fidelity USD Digital Liquidity Fund-Acc is currently rated as "fair value", while Injective scores 70.7 and is rated "undervalued". This means our algorithm considers Injective the fundamentally stronger investment — with a significant gap of 27.1 points.
Market Cap & Risk
Injective has a 11x larger market capitalization than Fidelity USD Digital Liquidity Fund-Acc. A larger market cap typically means less volatility but also less growth potential. Fidelity USD Digital Liquidity Fund-Acc may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, Fidelity USD Digital Liquidity Fund-Acc moved 0.00%, while Injective changed 4.00%. Looking at the 7-day window, Fidelity USD Digital Liquidity Fund-Acc is at 0.10% and Injective at -9.10%.
Distance from All-Time High
Fidelity USD Digital Liquidity Fund-Acc currently trades at 100% of its all-time high ($100.78), while Injective sits at 9% of its ATH ($52.62). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, Injective (Score: 70.7) currently has a stronger investment case than Fidelity USD Digital Liquidity Fund-Acc (Score: 43.6). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
